PMH21 DIFFERENCES IN DAILY AVERAGE CONSUMPTION AND DAILY COSTS OF DESVENLAFAXINE, VENLAFAXINE XR, DULOXETINE, AND ESCITALOPRAM AMONG COMMERCIALLY INSURED PATIENTS
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.1045
https://www.valueinhealthjournal.com/article/S1098-3015(11)01184-3/fulltext
Section Title :
Disease-Specific Studies
Section Order :
523
First Page :
A189
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01184-3&doi=10.1016/j.jval.2011.02.1045